Dr Reddys Laboratories (RDY) Asset Writedowns and Impairment (2009 - 2026)

Dr Reddys Laboratories has reported Asset Writedowns and Impairment for 18 years, with the latest figure at $158441.4 in Q2 2026.

• On a quarterly basis, Asset Writedowns and Impairment fell 99.17% year-over-year to $158441.4 in Q2 2026; TTM through Jun 2026 was $39.1 million, a 0.31% change from a year earlier, with the FY2026 full-year figure at $38.0 million, up 90.0% from the prior year.
• Asset Writedowns and Impairment was $158441.4 for Q2 2026 at Dr Reddys Laboratories, down from $28.3 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $99.9 million in Q1 2022, with the low at -$2.1 million in Q1 2024.
• Average Asset Writedowns and Impairment over 5 years is $12.0 million, with a median of $3.0 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment slumped 103.59% in 2024, then soared 31773.48% in 2025.
• Over 5 years, Asset Writedowns and Impairment stood at $7.0 million in 2022, then sank by 81.13% to $1.3 million in 2023, then slumped by 103.59% to -$47374.8 in 2024, then soared by 6523.65% to $3.0 million in 2025, then sank by 94.79% to $158441.4 in 2026.
• The last three Asset Writedowns and Impairment figures came in at $158441.4 (Q2 2026), $28.3 million (Q1 2026), and $3.0 million (Q4 2025), per Business Quant data.